Literature DB >> 34916185

[Renal sympathetic denervation can significantly reduce blood pressure and improve arterial stiffness in hypertensive beagles].

F Ye1, G Shi2, X Wang1, S Tu1, Z Zhang1, L Zeng1.   

Abstract

OBJECTIVE: To investigate the effect of renal sympathetic denervation (RDN) on blood pressure and arterial stiffness in hypertensive beagles and explore the underlying mechanism.
METHODS: Sixteen beagles were randomly divided into RDN group (n=8, fed with a high-salt high-fat diet to establish models of hypertension and treated with RDN), sham-operated group (n=4, fed with a high-salt high-fat diet to induce hypertension but only examined with renal arteriography) and control group (n=4, fed with formula dog food). The changes in blood pressure, arterial stiffness, endothelial function, and sympathetic activity were compared among the 3 groups and correlation analysis was performed.
RESULTS: All the animal models of hypertension were established successfully in the beagles. At 3 months after the RDN, the changes in systolic blood pressure (SBP) differed significantly among the 3 groups (P=0.006), and the reduction in SBP was significantly greater in RDN group than in the other two groups (P < 0.05). The variations of diastolic blood pressure (DBP) also differed significantly among the 3 groups (P=0.016), and DBP reduction was more obvious in RDN group than in the control group (P=0.007), but similar to that in the sham-operated group (P=0.052). The changes of resistance index (RI) after the procedure were significantly different among the 3 groups (P=0.043), and the RDN group showed a greater reduction of RI than the control group (P=0.032) and sham group (P=0.043). Serum levels of eNOS, NO and Ang Ⅱ did not differ significantly among the groups either before or after RDN (P>0.05), but serum NE level was significantly higher in RDN group than in the control groupafter successful modeling (P=0.014), but similar to that in the sham group (P=0.560). Compared with the sham operation, RDN in the hypertensive beagles resulted in a significantly greater decrease of serum NE level (P=0.032) to almost the control level (P= 0.080). The changes of RI following RDN were significantly correlated with the changes of SBP, DBP and serum levels of NO and NE (P < 0.05).
CONCLUSION: RDN can significantly reduce blood pressure and improve arterial stiffness in hypertensive beagles possibly by reducing sympathetic activity and blood pressure and promoting NO synthesis.

Entities:  

Keywords:  arterial stiffness; hypertension; renal sympathetic denervation; sympathetic activity

Mesh:

Year:  2021        PMID: 34916185      PMCID: PMC8685710          DOI: 10.12122/j.issn.1673-4254.2021.11.03

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  27 in total

Review 1.  Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity.

Authors:  Agne Frismantiene; Maria Philippova; Paul Erne; Therese J Resink
Journal:  Cell Signal       Date:  2018-08-30       Impact factor: 4.315

2.  Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF.

Authors:  David E Kandzari; Raymond R Townsend; George Bakris; Jan Basile; Michael J Bloch; Debbie L Cohen; Cara East; Keith C Ferdinand; Naomi Fisher; Ajay Kirtane; David P Lee; Gary Puckrein; Florian Rader; Joseph A Vassalotti; Michael A Weber; Kerry Willis; Eric Secemsky
Journal:  Catheter Cardiovasc Interv       Date:  2021-08-03       Impact factor: 2.692

3.  Renal denervation therapy beyond resistant hypertension.

Authors:  Amir Solomonica; Shahar Lavi; Tawfiq Choudhury; Rodrigo Bagur
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 4.  Interaction Between Hypertension and Arterial Stiffness.

Authors:  Michel E Safar; Roland Asmar; Athanase Benetos; Jacques Blacher; Pierre Boutouyrie; Patrick Lacolley; Stéphane Laurent; Gérard London; Bruno Pannier; Athanase Protogerou; Véronique Regnault
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

5.  Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Authors:  Michel Azizi; Roland E Schmieder; Felix Mahfoud; Michael A Weber; Joost Daemen; Justin Davies; Jan Basile; Ajay J Kirtane; Yale Wang; Melvin D Lobo; Manish Saxena; Lida Feyz; Florian Rader; Philipp Lurz; Jeremy Sayer; Marc Sapoval; Terry Levy; Kintur Sanghvi; Josephine Abraham; Andrew S P Sharp; Naomi D L Fisher; Michael J Bloch; Helen Reeve-Stoffer; Leslie Coleman; Christopher Mullin; Laura Mauri
Journal:  Lancet       Date:  2018-05-23       Impact factor: 79.321

Review 6.  Methodological standardization for the pre-clinical evaluation of renal sympathetic denervation.

Authors:  Kenichi Sakakura; Elena Ladich; Elazer R Edelman; Peter Markham; James R L Stanley; John Keating; Frank D Kolodgie; Renu Virmani; Michael Joner
Journal:  JACC Cardiovasc Interv       Date:  2014-09-17       Impact factor: 11.195

7.  Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.

Authors:  Dominik Linz; Felix Mahfoud; Ulrich Schotten; Christian Ukena; Hans-Ruprecht Neuberger; Klaus Wirth; Michael Böhm
Journal:  Hypertension       Date:  2012-05-14       Impact factor: 10.190

8.  Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.

Authors:  Michael Böhm; Kazuomi Kario; David E Kandzari; Felix Mahfoud; Michael A Weber; Roland E Schmieder; Konstantinos Tsioufis; Stuart Pocock; Dimitris Konstantinidis; James W Choi; Cara East; David P Lee; Adrian Ma; Sebastian Ewen; Debbie L Cohen; Robert Wilensky; Chandan M Devireddy; Janice Lea; Axel Schmid; Joachim Weil; Tolga Agdirlioglu; Denise Reedus; Brian K Jefferson; David Reyes; Richard D'Souza; Andrew S P Sharp; Faisal Sharif; Martin Fahy; Vanessa DeBruin; Sidney A Cohen; Sandeep Brar; Raymond R Townsend
Journal:  Lancet       Date:  2020-03-29       Impact factor: 79.321

9.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

10.  Accurate Depth of Radiofrequency-Induced Lesions in Renal Sympathetic Denervation Based on a Fine Histological Sectioning Approach in a Porcine Model.

Authors:  Atsushi Sakaoka; Hisako Terao; Shintaro Nakamura; Hitomi Hagiwara; Toshihito Furukawa; Kiyoshi Matsumura; Kenichi Sakakura
Journal:  Circ Cardiovasc Interv       Date:  2018-02       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.